Skip to content

Drug interactions

Mirvetuximab soravtansine + Voriconazole

Severity: Moderate

Mirvetuximab soravtansine and Voriconazole: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Strong CYP3A inhibitors may increase exposure to the cytotoxic payload DM4 released from mirvetuximab. This can increase toxicities such as ocular, hematologic and hepatic adverse effects.

What this interaction means in plain words

Mirvetuximab soravtansine and Voriconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mirvetuximab soravtansine belongs to Oncology; Voriconazole belongs to Anti Fungals.

Evidence level: Low

Why it happens

Voriconazole inhibits CYP3A4 metabolism of unconjugated DM4.

What to do

Monitor closely for adverse reactions, especially ocular toxicity and neutropenia. Consider a non-CYP3A-inhibiting antifungal if feasible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mirvetuximab soravtansine and Voriconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mirvetuximab soravtansine with Voriconazole?

MediHelp rates the interaction as moderate. Mirvetuximab soravtansine and Voriconazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Strong CYP3A inhibitors may increase exposure to the cytotoxic payload DM4 released from mirvetuximab. This can increase toxicities such as ocular, hematologic and hepatic adverse effects.

How serious is the interaction between Mirvetuximab soravtansine and Voriconazole?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor closely for adverse reactions, especially ocular toxicity and neutropenia. Consider a non-CYP3A-inhibiting antifungal if feasible.

What other medicines interact with Voriconazole?

MediHelp also lists interactions of Voriconazole with, for example, Avanafil, Butabarbital, Carbamazepine. The full list is on the Voriconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in